Anti‐tissue transglutaminase antibodies in the follow‐up of adult coeliac disease

Abstract

This study supports a strategy of using anti-tTG antibody concentrations to monitor newly diagnosed and established patients with coeliac disease, and to target dietetic intervention to reduce the risk of complication.